Chemical Structure : NAMPT activator compound b2b
货号: PC-27316Not For Human Use, Lab Use Only.
NAMPT activator compound b2b is a potent lipid-lowering compound (EC50=0.37 uM) and NAMPT activator, binds to NAMPT with a dissociation constant (KD) of 0.78 uM, inhibits triglyceride biosynthesis by inhibiting ACSL1 in adipocytes.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NAMPT activator compound b2b is a potent lipid-lowering compound (EC50=0.37 uM) and NAMPT activator, binds to NAMPT with a dissociation constant (KD) of 0.78 uM, inhibits triglyceride biosynthesis by inhibiting ACSL1 in adipocytes.
b2b suppressed lipid accumulation throughout all stages of adipocyte differentiation.
b2b attenuates diet-induced obesity and improves metabolic health in mice.
b2b disrupts LCFA flux and triglyceride biosynthesis by inhibiting the expression of ACSL1 in 3T3-L1 adipocytes.
b2b inhibits TG biosynthesis by regulating ACSL1 expression through NAMPT-NAD+-SIRT1 axis.
| 分子量 | 372.45 | |
| 分子式 | C21H16N4OS | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Zhi Jiang, et al. Acta Pharm Sin B. 2026 Jul;16(7):4478-4490.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright